Tobacco dependence treatment guidelines. 2022

Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková

These recommendations are relevant for all clinical fields and all medical professions, although for some more and for some less. Smoking is the cause of every sixth death in the Czech Republic and is related to diseases of all organ systems. Effective treatment for the diagnosis of F17 exists and should be offered and available to approximately 2 million smokers in the Czech Republic as a standard part of medical and preventive care according to time availability - from brief intervention in frame of each clinical contact with the patient to intensive care. It includes psycho-socio-behavioral support and pharmacotherapy. It should cover all professions in clinical medicine - according to WHO recommendations, especially doctors, nurses, pharmacists and dentists and should be reimbursed within health systems. It should also be offered in other services like e.g., social or addictology care. From an economic point of view, it is one of the most cost-effective interventions in medicine.

UI MeSH Term Description Entries
D010595 Pharmacists Those persons legally qualified by education and training to engage in the practice of pharmacy. Clinical Pharmacists,Community Pharmacists,Retail Pharmacists,Clinical Pharmacist,Community Pharmacist,Pharmacist,Pharmacist, Clinical,Pharmacist, Community,Pharmacist, Retail,Pharmacists, Clinical,Pharmacists, Community,Pharmacists, Retail,Retail Pharmacist
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D014029 Tobacco Use Disorder Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included. Nicotine Addiction,Nicotine Dependence,Nicotine Use Disorder,Tobacco Dependence,Tobacco-Use Disorder,Addiction, Nicotine,Dependence, Nicotine,Dependence, Tobacco,Disorder, Nicotine Use,Disorder, Tobacco Use,Disorder, Tobacco-Use,Nicotine Addictions,Nicotine Use Disorders,Tobacco Use Disorders
D016540 Smoking Cessation Discontinuing the habit of SMOKING. Giving Up Smoking,Quitting Smoking,Stopping Smoking,Cessation, Smoking,Smoking Cessations,Smoking, Giving Up,Smoking, Quitting,Smoking, Stopping,Smokings, Giving Up,Up Smoking, Giving

Related Publications

Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
February 2021, International journal of clinical pharmacy,
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
August 2013, Addiction (Abingdon, England),
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
February 2016, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
August 2013, Addiction (Abingdon, England),
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
July 2009, Addiction (Abingdon, England),
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
January 2013, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
August 2018, Addiction (Abingdon, England),
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
December 2011, Addiction (Abingdon, England),
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
April 2008, Mayo Clinic proceedings,
Eva Králíková, and Kamila Zvolská, and Lenka Štěpánková, and Alexandra Pánková
October 2002, JAMA,
Copied contents to your clipboard!